• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液细胞外囊泡中的MiR-30b-3p和MiR-126-3p可能成为前列腺癌的新型生物标志物。

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.

作者信息

Matsuzaki Kyosuke, Fujita Kazutoshi, Tomiyama Eisuke, Hatano Koji, Hayashi Yujiro, Wang Cong, Ishizuya Yu, Yamamoto Yoshiyuki, Hayashi Takuji, Kato Taigo, Jingushi Kentaro, Kawashima Atsunari, Ujike Takeshi, Nagahara Akira, Uemura Motohide, Tsujikawa Kazutake, Nonomura Norio

机构信息

Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.

Department of Urological Immuno-Oncology, Osaka University Graduate School of Medicine, Suita, Japan.

出版信息

Transl Androl Urol. 2021 Apr;10(4):1918-1927. doi: 10.21037/tau-20-421.

DOI:10.21037/tau-20-421
PMID:33968679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100845/
Abstract

BACKGROUND

Extracellular vesicles (EVs) including exosomes are present in blood, urine, and saliva and contain proteins, microRNAs, and messenger RNAs. We investigated microRNAs in urinary EVs to discover new biomarkers of prostate cancer (PCa).

METHODS

We isolated EVs from urine obtained following digital rectal examination (DRE) of 14 men with elevated levels of serum prostate-specific antigen (PSA) [negative biopsy (n=4) and PCa with Gleason scores of 6 (n=3), 7 (n=3), and 8-9 (n=4)]. MicroRNAs extracted from EVs were analyzed by microRNA microarray.

RESULTS

MicroRNAs miR-30b-3p and miR-126-3p were identified as being overexpressed in urinary EVs of the PCa patients versus the biopsy-negative men, but no microRNAs were associated with the Gleason score. In the independent cohort as well, these two microRNAs were overexpressed in urinary EVs from the PCa patients versus the negative-biopsy men. Logistic regression analysis adjusted by age and PSA showed that these two microRNAs were significantly associated with the prediction of PCa in biopsy specimens. Sensitivity and specificity of miR-30b-3p and miR-126-3p for the prediction of PCa were 46.4% and 88.0% and 60.7% and 80.0%, respectively, which were better than those of serum PSA (53.5% and 64.0%, respectively).

CONCLUSIONS

MiR-30b-3p and miR-126-3p in urinary EVs could be potential biomarkers of PCa.

摘要

背景

包括外泌体在内的细胞外囊泡(EVs)存在于血液、尿液和唾液中,含有蛋白质、微小RNA(miRNAs)和信使RNA。我们研究了尿液EVs中的miRNAs,以发现前列腺癌(PCa)的新生物标志物。

方法

我们从14名血清前列腺特异性抗原(PSA)水平升高的男性患者(阴性活检[n = 4]以及Gleason评分为6[n = 3]、7[n = 3]和8 - 9[n = 4]的PCa患者)经直肠指检(DRE)后获得的尿液中分离出EVs。通过miRNA微阵列分析从EVs中提取的miRNAs。

结果

与活检阴性的男性相比,miR - 30b - 3p和miR - 126 - 3p在PCa患者的尿液EVs中被鉴定为过表达,但没有miRNAs与Gleason评分相关。在独立队列中,与活检阴性的男性相比,这两种miRNAs在PCa患者的尿液EVs中也过表达。经年龄和PSA校正的逻辑回归分析表明,这两种miRNAs与活检标本中PCa的预测显著相关。miR - 30b - 3p和miR - 126 - 3p预测PCa的敏感性和特异性分别为46.4%和88.0%以及60.7%和80.0%,优于血清PSA(分别为53.5%和64.0%)。

结论

尿液EVs中的miR - 30b - 3p和miR - 126 - 3p可能是PCa的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/746ed288bc27/tau-10-04-1918-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/66b3338a7d60/tau-10-04-1918-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/d3d17f1fa136/tau-10-04-1918-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/d107fa037f6f/tau-10-04-1918-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/746ed288bc27/tau-10-04-1918-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/66b3338a7d60/tau-10-04-1918-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/d3d17f1fa136/tau-10-04-1918-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/d107fa037f6f/tau-10-04-1918-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d3e/8100845/746ed288bc27/tau-10-04-1918-f4.jpg

相似文献

1
MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.尿液细胞外囊泡中的MiR-30b-3p和MiR-126-3p可能成为前列腺癌的新型生物标志物。
Transl Androl Urol. 2021 Apr;10(4):1918-1927. doi: 10.21037/tau-20-421.
2
MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.基于静水压过滤透析法检测尿液细胞外囊泡中的MiR-145可提高前列腺癌的诊断效率。
Prostate. 2017 Jul;77(10):1167-1175. doi: 10.1002/pros.23376. Epub 2017 Jun 15.
3
Functional analysis of miR-21-3p, miR-30b-5p and miR-150-5p shuttled by extracellular vesicles from diabetic subjects reveals their association with diabetic retinopathy.由糖尿病患者细胞外囊泡转运的 miR-21-3p、miR-30b-5p 和 miR-150-5p 的功能分析揭示了它们与糖尿病视网膜病变的关系。
Exp Eye Res. 2019 Jul;184:56-63. doi: 10.1016/j.exer.2019.04.015. Epub 2019 Apr 16.
4
Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.缺氧胶质瘤干细胞衍生的细胞外囊泡通过递送 miR-30b-3p 赋予胶质母细胞瘤替莫唑胺耐药性。
Theranostics. 2021 Jan 1;11(4):1763-1779. doi: 10.7150/thno.47057. eCollection 2021.
5
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.前列腺癌和良性前列腺增生中血清微小RNA的不同水平:潜在诊断和预后作用的评估
Onco Targets Ther. 2016 Dec 13;9:7545-7553. doi: 10.2147/OTT.S119027. eCollection 2016.
6
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.基于尿液微小RNA的标志物可提高在前列腺特异性抗原灰色区域内检测临床相关前列腺癌的准确性。
Mol Med Rep. 2016 Jun;13(6):4549-60. doi: 10.3892/mmr.2016.5095. Epub 2016 Apr 8.
7
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.尿细胞外囊泡衍生的miR-126-3p可预测高危前列腺癌患者的淋巴结浸润。
Res Sq. 2024 Mar 29:rs.3.rs-4164213. doi: 10.21203/rs.3.rs-4164213/v1.
8
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.尿细胞外囊泡来源的 miR-126-3p 预测高危前列腺癌患者的淋巴结侵犯。
Med Oncol. 2024 Jun 5;41(7):169. doi: 10.1007/s12032-024-02400-x.
9
Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.用于前列腺癌诊断和血浆及尿液细胞外囊泡监测的潜在RNA生物标志物的验证
Front Mol Biosci. 2023 Nov 30;10:1279854. doi: 10.3389/fmolb.2023.1279854. eCollection 2023.
10
High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer.用于鉴定具有前列腺癌诊断潜力的微小RNA的细胞外囊泡的高通量自动化声学捕获
Front Oncol. 2021 Mar 25;11:631021. doi: 10.3389/fonc.2021.631021. eCollection 2021.

引用本文的文献

1
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders.外泌体生物标志物:恶性和非恶性疾病诊断及预后应用的全面概述
Biomolecules. 2025 Apr 15;15(4):587. doi: 10.3390/biom15040587.
2
Identification and Characterization of Differentially Expressed MicroRNAs in Benign Prostatic Hyperplasia.良性前列腺增生中差异表达的微小RNA的鉴定与表征
Cancer Rep (Hoboken). 2025 Apr;8(4):e70178. doi: 10.1002/cnr2.70178.
3
Epigenetic Modifications Associated With Wildland-Urban Interface (WUI) Firefighting.

本文引用的文献

1
Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2-10 ng/mL.基于外泌体的 ExoDx Prostate(IntelliScore) EPI 检测在 PSA 2-10ng/mL 初始活检男性中的临床应用。
Prostate Cancer Prostatic Dis. 2020 Dec;23(4):607-614. doi: 10.1038/s41391-020-0237-z. Epub 2020 May 7.
2
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
3
Urinary biomarkers of prostate cancer.前列腺癌的尿液生物标志物
与城乡结合部(WUI)灭火相关的表观遗传修饰
Environ Mol Mutagen. 2025 Jan-Feb;66(1-2):22-33. doi: 10.1002/em.70002. Epub 2025 Feb 19.
4
Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response.前列腺癌中的外泌体液体活检:诊断、预后和治疗反应生物标志物的系统评价
Int J Mol Sci. 2025 Jan 18;26(2):802. doi: 10.3390/ijms26020802.
5
Liquid biopsy in cancer current: status, challenges and future prospects.癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
6
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.尿细胞外囊泡来源的 miR-126-3p 预测高危前列腺癌患者的淋巴结侵犯。
Med Oncol. 2024 Jun 5;41(7):169. doi: 10.1007/s12032-024-02400-x.
7
Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects.前列腺癌诊断中的液体生物标志物:现状与新兴前景
World J Mens Health. 2025 Jan;43(1):8-27. doi: 10.5534/wjmh.230386. Epub 2024 Apr 11.
8
Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer.尿细胞外囊泡在前列腺癌诊断及主动监测中的应用
Cancers (Basel). 2024 Apr 28;16(9):1717. doi: 10.3390/cancers16091717.
9
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.尿细胞外囊泡衍生的miR-126-3p可预测高危前列腺癌患者的淋巴结浸润。
Res Sq. 2024 Mar 29:rs.3.rs-4164213. doi: 10.21203/rs.3.rs-4164213/v1.
10
Potential Druggability of Mesenchymal Stem/Stromal Cell-derived Exosomes.间充质干细胞/基质细胞衍生的外泌体的潜在成药性。
Curr Stem Cell Res Ther. 2024;19(9):1195-1209. doi: 10.2174/011574888X311270240319084835.
Int J Urol. 2018 Sep;25(9):770-779. doi: 10.1111/iju.13734. Epub 2018 Aug 21.
4
MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9.微小RNA-126通过调控解聚素金属蛋白酶9抑制前列腺癌的增殖和转移。
Oncol Lett. 2018 Jun;15(6):9051-9060. doi: 10.3892/ol.2018.8528. Epub 2018 Apr 18.
5
Extracellular vesicles: Toward a clinical application in urological cancer treatment.细胞外囊泡:迈向泌尿外科癌症治疗的临床应用
Int J Urol. 2018 Jun;25(6):533-543. doi: 10.1111/iju.13594. Epub 2018 May 3.
6
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.通过对尿液外泌体的深度测序分析鉴定前列腺癌的非侵入性 miRNA 生物标志物。
Mol Cancer. 2017 Oct 5;16(1):156. doi: 10.1186/s12943-017-0726-4.
7
Urinary-exosomal miR-2909: A novel pathognomonic trait of prostate cancer severity.尿外泌体 miR-2909:前列腺癌严重程度的新型特征性指标。
J Biotechnol. 2017 Oct 10;259:135-139. doi: 10.1016/j.jbiotec.2017.07.029. Epub 2017 Jul 29.
8
MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.基于静水压过滤透析法检测尿液细胞外囊泡中的MiR-145可提高前列腺癌的诊断效率。
Prostate. 2017 Jul;77(10):1167-1175. doi: 10.1002/pros.23376. Epub 2017 Jun 15.
9
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.联合 TMPRSS2:ERG 和 PCA3 RNA 尿检测与侵袭性前列腺癌的检出相关。
JAMA Oncol. 2017 Aug 1;3(8):1085-1093. doi: 10.1001/jamaoncol.2017.0177.
10
Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.高 Gleason 评分前列腺癌患者尿细胞外囊泡的蛋白质组学分析。
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.